Abacus Life Reports Preliminary Q2 Total Revenue Of $28M - $30M, Up 146-163% Y/Y (Est $21.893M)
$ABL
Investment Managers
Finance
Abacus Life Reports Preliminary Q2 Total Revenue Of $28M - $30M, Up 146-163% Y/Y (Est $21.893M)
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/24/2024 | $13.50 | Outperform | Northland Capital |
| 8/7/2024 | $14.00 | Buy | TD Cowen |
| 6/26/2024 | $12.00 | Overweight | Piper Sandler |
| 5/31/2024 | $16.00 | Buy | B. Riley Securities |
ORLANDO, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. ("Abacus" or the "Company") (NASDAQ:ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the pricing of its underwritten public offering of 12,500,000 shares of its common stock, including 10,000,000 shares of common stock being offered by the Company and 2,500,000 shares of common stock being offered by certain stockholders of the Company (the "Selling Stockholders"), at a price to the public of $8.00 per share. In connection with the offering, the Company also granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stoc
ORLANDO, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. ("Abacus" or the "Company") (NASDAQ:ABL), a pioneering alternative asset manager specializing in leveraging longevity and actuarial technology to offer uncorrelated investment opportunities, today announced the commencement of an underwritten public offering of 12,500,000 shares of its common stock, including 10,000,000 shares of common stock to be sold by the Company and 2,500,000 to be sold by certain stockholders of the Company (the "Selling Stockholders"). The Company and the Selling Stockholders also expect to grant the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stock from t
- Delivered Continued Revenue and Profitability Growth While Executing on Strategic Initiatives - - Third Quarter 2024 Total Revenue Grows 33% Year-over-Year to $28.1 Million - - Due to Non-Cash Increase in Warrant Liability of $8.7M; GAAP Net Loss of $5.1M - - Adjusted Net Income Grows 65% Year-over-Year to $14.9 Million - - Adjusted EBITDA Grows 54% Year-over-Year to $16.7 Million - ORLANDO, Fla., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. ("Abacus" or the "Company") (NASDAQ:ABL), a pioneering global alternative asset manager specializing in leveraging longevity data and actuarial technology to offer uncorrelated investment opportunities, today reported results for the thir
Northland Capital initiated coverage of Abacus Life with a rating of Outperform and set a new price target of $13.50
TD Cowen initiated coverage of Abacus Life with a rating of Buy and set a new price target of $14.00
Piper Sandler initiated coverage of Abacus Life with a rating of Overweight and set a new price target of $12.00
U.S. stocks were lower, with the Dow Jones index falling around 250 points on Friday. Shares of Western Alliance Bancorporation (NYSE:WAL) rose sharply during Friday's session following upbeat quarterly results. Western Alliance reported quarterly earnings of $1.75 per share which beat the analyst consensus estimate of $1.71 per share. The company reported quarterly sales of $771.80 million which beat the analyst consensus estimate of $737.64 million, according to data from Benzinga Pro. Western Alliance Bancorporation shares gained 7.2% to $76.16 on Friday. Here are some other big stocks recording gains in today’s session. Hawaiian Electric Industries, Inc. (NYSE:HE) shares
ORLANDO, Fla., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (NASDAQ:ABL) ("Abacus Life" or the "Company"), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the appointment of Robert F. Phillips as Senior Vice President, Investor Relations and Corporate Affairs, effective immediately. Mr. Phillips brings over 30 years of diverse experience in capital markets and investor relations to Abacus Life, with a proven track record of strategic leadership in the financial sector. Reporting directly to Jay Jackson, Chairman and Chief Executive Officer of Abacus Life, Mr. Phillips will lead Abacus Life's investor relations strategy to s
ORLANDO, Fla., April 18, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (NASDAQ:ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the appointment of Fei Xue as Vice President of ABL Wealth. Based in Orlando, Ms. Xue brings nearly two decades of experience in asset and wealth management. Having worked at Dynasty Financial Partners most recently, Ms. Xue served as a strategic advisor to some of the largest and most successful Registered Investment Advisors (RIAs) across the country. She partnered with sophisticated leadership teams to help scale their businesses, enhance investment offerings, build efficiencies, and better care fo
ORLANDO, Fla. and BOCA RATON, Fla., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Abacus Life, Inc. ("Abacus" or the "Company") (NASDAQ:ABL), a leading buyer of life insurance policies, policy originator and alternative asset manager specializing in specialty insurance products, today announced that Christopher Romaine has been appointed as General Counsel and will advise and serve on the Company's executive leadership team. Romaine brings 25 years of leadership experience in global specialty insurance, financial services and corporate development and previously held senior roles at Fortegra, including serving as General Counsel and Chief Operating Officer. Prior to Fortegra, Romaine served as couns
- Delivered Continued Revenue and Profitability Growth While Executing on Strategic Initiatives - - Third Quarter 2024 Total Revenue Grows 33% Year-over-Year to $28.1 Million - - Due to Non-Cash Increase in Warrant Liability of $8.7M; GAAP Net Loss of $5.1M - - Adjusted Net Income Grows 65% Year-over-Year to $14.9 Million - - Adjusted EBITDA Grows 54% Year-over-Year to $16.7 Million - ORLANDO, Fla., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. ("Abacus" or the "Company") (NASDAQ:ABL), a pioneering global alternative asset manager specializing in leveraging longevity data and actuarial technology to offer uncorrelated investment opportunities, today reported results for the thir
- Expects Total Revenue Between $26.0 and $28.0 Million; Grows 23-33% Year-over-Year - - Expects GAAP Net Income / (Loss) Between ($6.0) and ($6.75) Million Due to Non-Cash Increase in Warrant Liability of Between $8.0 and $9.0 Million - - Expects Adjusted EBITDA Between $14.0 and $16.0 Million; Grows 30-48% Year-over-Year - - Third Quarter 2024 Earnings Release and Conference Call to be Held Thursday, November 7, 2024 - ORLANDO, Fla., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. ("Abacus" or the "Company") (NASDAQ:ABL), a leading global alternative asset manager focused on lifespan-based financial products, today announced preliminary unaudited financial results for the third q
ORLANDO, Fla., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. ("Abacus" or the "Company") (NASDAQ:ABL), a leading global alternative asset manager focused on lifespan-based financial products, today announced it will release its Third Quarter 2024 financial results after the market closes on Thursday, November 7, 2024. Abacus will hold a conference call to discuss the financial results at 5:00 pm Eastern Time on November 7, 2024. A live webcast of the conference call will be available on Abacus' investor relations website at ir.abacuslife.com. The dial-in number for the conference call is (800) 267-6316 (toll-free) or (203) 518-9783 (international), followed by the required Conferenc